NEB-Related Nemaline Myopathy, 1 Variant
Ordering Recommendation

Carrier screening or diagnostic testing for NEB-related nemaline myopathy for individuals of Ashkenazi Jewish descent.

Polymerase Chain Reaction/Fluorescence Monitoring
Tue, Fri
5-10 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
Lavender (EDTA), pink (K2EDTA), or yellow (ACD Solution A or B). 
Specimen Preparation
Transport 3 mL whole blood. (Min: 1 mL) 
Storage/Transport Temperature
Unacceptable Conditions
Plasma or serum. Specimens collected in sodium heparin or lithium heparin tubes. 
Ambient: 72 hours; Refrigerated: 2 weeks; Frozen: 1 month 
Reference Interval
By report
Interpretive Data
Background Information for NEB-Related Nemaline Myopathy, 1 Variant:
Characteristics: NEB-related nemaline myopathy typically presents within the first year of life with hypotonia, feeding difficulties and muscle weakness of the face, neck, arms and legs. Muscle weakness is static or progresses very slowly, but lifespan is not usually decreased.
Incidence: 1 in 47,000 in Ashkenazi Jewish individuals.
Inheritance: Autosomal recessive.
Cause: NEB pathogenic variants.
Variant Tested: Exon 55 del (p.R2478_D2512del).
Clinical Sensitivity: 99 percent in Ashkenazi Jewish individuals; unknown in other ethnicities.
Methodology: Polymerase chain reaction (PCR) and fluorescence monitoring.
Analytical Sensitivity and Specificity: Greater than 99 percent.
Limitations: Variants other than exon 55 del will not be detected. Diagnostic errors can occur due to rare sequence variations.

Statement C: Compliance Statement C: For human genetic inheritable conditions and mutations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Counseling and informed consent are recommended for genetic testing. Consent forms are available online.

Hotline History
Component Test Code*Component Chart NameLOINC
2013746NEB-Related Nemaline Myopathy, Specimen
2013747NEB-Related Nemaline Myopathy, Allele 1
2013748NEB-Related Nemaline Myopathy, Allele 2
2013749NEB-Related Nemaline Myopathy, Interp
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please view this test within the Laboratory Test Directory found at